PML/RARA (promyelocytic leukemia/retinoic acid receptor alpha) fusion gene quick detection probe with low cost and preparation method and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- WUHAN HEALTHCHART BIOLOGICAL TECH
- Publication Date
- 2017-07-07
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of molecular biology, and in particular relates to a low-cost rapid detection probe of PML / RARA fusion gene and its preparation method and application. Background technique
[0002] Detection of PML / RARA fusion gene is one of the most specific and sensitive methods for diagnosing acute promyelocytic leukemia (APL), and it is also the most reliable indicator for APL treatment options, curative effect analysis and prognosis analysis. At present, karyotype analysis, PCR method and FISH method are several common detection methods. FISH has the advantages of safety, rapidity, high sensitivity and simultaneous display of multiple colors.
[0003] Fluorescence in situ hybridization is a non-radioactive molecular genetic technique developed on the basis of radioactive in situ hybridization in the 1980s. It is a new in situ hybridization method formed by replacing radioactive isotope labels with fluorescein labels. At presen...